100+ datasets found
  1. G

    HIV infections by country, around the world | TheGlobalEconomy.com

    • theglobaleconomy.com
    csv, excel, xml
    Updated Apr 24, 2015
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Globalen LLC (2015). HIV infections by country, around the world | TheGlobalEconomy.com [Dataset]. www.theglobaleconomy.com/rankings/HIV_infections/
    Explore at:
    xml, excel, csvAvailable download formats
    Dataset updated
    Apr 24, 2015
    Dataset authored and provided by
    Globalen LLC
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Dec 31, 1990 - Dec 31, 2022
    Area covered
    World, World
    Description

    The average for 2022 based on 135 countries was 1.66 percent. The highest value was in Swaziland: 25.9 percent and the lowest value was in Afghanistan: 0.1 percent. The indicator is available from 1990 to 2022. Below is a chart for all countries where data are available.

  2. Countries with the highest prevalence of HIV in 2000 and 2023

    • statista.com
    • ai-chatbox.pro
    Updated Jun 23, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2025). Countries with the highest prevalence of HIV in 2000 and 2023 [Dataset]. https://www.statista.com/statistics/270209/countries-with-the-highest-global-hiv-prevalence/
    Explore at:
    Dataset updated
    Jun 23, 2025
    Dataset authored and provided by
    Statistahttp://statista.com/
    Area covered
    Worldwide
    Description

    Among all countries worldwide those in sub-Saharan Africa have the highest rates of HIV. The countries with the highest rates of HIV include Eswatini, Lesotho, and South Africa. In 2023, Eswatini had the highest prevalence of HIV with a rate of around ** percent. Other countries, such as Zimbabwe, have significantly decreased their HIV prevalence. Community-based HIV services are considered crucial to the prevention and treatment of HIV. HIV Worldwide The human immunodeficiency virus (HIV) is a viral infection that is transmitted via exposure to infected semen, blood, vaginal and anal fluids and breast milk. HIV destroys the human immune system, rendering the host unable to fight off secondary infections. Globally, the number of people living with HIV has generally increased over the past two decades. However, the number of HIV-related deaths has decreased significantly in recent years. Despite being a serious illness that affects millions of people, medication exists that effectively manages the progression of the virus in the body. These medications are called antiretroviral drugs. HIV Treatment Generally, global access to antiretroviral treatment has increased in recent years. However, despite being available worldwide, not all adults have access to antiretroviral drugs. Europe and North America have the highest rates of antiretroviral use among people living with HIV. There are many different antiretroviral drugs available on the market. As of 2024, ********, an antiretroviral marketed by Gilead, was the leading HIV treatment based on revenue.

  3. Rates of HIV diagnoses in the United States in 2022, by state

    • statista.com
    • ai-chatbox.pro
    Updated Apr 9, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2025). Rates of HIV diagnoses in the United States in 2022, by state [Dataset]. https://www.statista.com/statistics/257734/us-states-with-highest-aids-diagnosis-rates/
    Explore at:
    Dataset updated
    Apr 9, 2025
    Dataset authored and provided by
    Statistahttp://statista.com/
    Time period covered
    2022
    Area covered
    United States
    Description

    The states with the highest rates of HIV diagnoses in 2022 included Georgia, Louisiana, and Florida. However, the states with the highest number of people with HIV were Texas, California, and Florida. In Texas, there were around 4,896 people diagnosed with HIV. HIV/AIDS diagnoses In 2022, there were an estimated 38,043 new HIV diagnoses in the United States, a slight increase compared to the year before. Men account for the majority of these new diagnoses. There are currently around 1.2 million people living with HIV in the United States. Deaths from HIV The death rate from HIV has decreased significantly over the past few decades. In 2023, there were only 1.3 deaths from HIV per 100,000 population, the lowest rate since the epidemic began. However, the death rate varies greatly depending on race or ethnicity, with the death rate from HIV for African Americans reaching 19.2 per 100,000 population in 2022, compared to just three deaths per 100,000 among the white population.

  4. United States US: Prevalence of HIV: Total: % of Population Aged 15-49

    • ceicdata.com
    Updated Nov 27, 2021
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    CEICdata.com (2021). United States US: Prevalence of HIV: Total: % of Population Aged 15-49 [Dataset]. https://www.ceicdata.com/en/united-states/health-statistics/us-prevalence-of-hiv-total--of-population-aged-1549
    Explore at:
    Dataset updated
    Nov 27, 2021
    Dataset provided by
    CEIC Data
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Dec 1, 2008 - Dec 1, 2014
    Area covered
    United States
    Description

    United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data was reported at 0.500 % in 2014. This stayed constant from the previous number of 0.500 % for 2013. United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data is updated yearly, averaging 0.500 % from Dec 2008 (Median) to 2014, with 7 observations. The data reached an all-time high of 0.500 % in 2014 and a record low of 0.500 % in 2014. United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Prevalence of HIV refers to the percentage of people ages 15-49 who are infected with HIV.; ; UNAIDS estimates.; Weighted Average;

  5. Number of people with HIV in select countries in Africa 2023

    • statista.com
    • ai-chatbox.pro
    Updated Aug 21, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Statista (2024). Number of people with HIV in select countries in Africa 2023 [Dataset]. https://www.statista.com/statistics/1305217/number-people-with-hiv-african-countries/
    Explore at:
    Dataset updated
    Aug 21, 2024
    Dataset authored and provided by
    Statistahttp://statista.com/
    Time period covered
    2023
    Area covered
    Africa
    Description

    As of 2023, South Africa was the country with the highest number of people living with HIV in Africa. At that time, around 7.7 million people in South Africa were HIV positive. In Mozambique, the country with the second-highest number of HIV-positive people in Africa, around 2.4 million people were living with HIV. Which country in Africa has the highest prevalence of HIV? Although South Africa has the highest total number of people living with HIV in Africa, it does not have the highest prevalence of HIV on the continent. Eswatini currently has the highest prevalence of HIV in Africa and worldwide, with almost 26 percent of the population living with HIV. South Africa has the third-highest prevalence, with around 18 percent of the population HIV positive. Eswatini also has the highest rate of new HIV infections per 1,000 population worldwide, followed by Lesotho and South Africa. However, South Africa had the highest total number of new HIV infections in 2023, with around 150,000 people newly infected with HIV that year. Deaths from HIV in Africa Thanks to advances in treatment and awareness, HIV/AIDS no longer contributes to a significant amount of death in many countries. However, the disease is still the fourth leading cause of death in Africa, accounting for around 5.6 percent of all deaths. In 2023, South Africa and Nigeria were the countries with the highest number of AIDS-related deaths worldwide with 50,000 and 45,000 such deaths, respectively. Although not every country in the leading 25 for AIDS-related deaths is found in Africa, African countries account for the majority of countries on the list. Fortunately, HIV treatment has become more accessible in Africa over the years and now up to 95 percent of people living with HIV in Eswatini are receiving antiretroviral therapy (ART). Access to ART does vary from country to country, however, with around 77 percent of people who are HIV positive in South Africa receiving ART, and only 31 percent in the Congo.

  6. T

    World - Prevalence Of HIV, Male (% Ages 15-24)

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Jun 5, 2017
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2017). World - Prevalence Of HIV, Male (% Ages 15-24) [Dataset]. https://tradingeconomics.com/world/prevalence-of-hiv-male-percent-ages-15-24-wb-data.html
    Explore at:
    csv, xml, json, excelAvailable download formats
    Dataset updated
    Jun 5, 2017
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 1976 - Dec 31, 2025
    Area covered
    World, World
    Description

    Prevalence of HIV, male (% ages 15-24) in World was reported at 0.2 % in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. World - Prevalence of HIV, male (% ages 15-24) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

  7. U

    United Arab Emirates AE: Incidence of HIV: per 1,000 Uninfected Population

    • ceicdata.com
    Updated Jun 15, 2024
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    CEICdata.com (2024). United Arab Emirates AE: Incidence of HIV: per 1,000 Uninfected Population [Dataset]. https://www.ceicdata.com/en/united-arab-emirates/health-statistics/ae-incidence-of-hiv-per-1000-uninfected-population
    Explore at:
    Dataset updated
    Jun 15, 2024
    Dataset provided by
    CEICdata.com
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Dec 1, 2009 - Dec 1, 2020
    Area covered
    United Arab Emirates
    Description

    United Arab Emirates AE: Incidence of HIV: per 1,000 Uninfected Population data was reported at 0.130 Ratio in 2020. This records an increase from the previous number of 0.120 Ratio for 2019. United Arab Emirates AE: Incidence of HIV: per 1,000 Uninfected Population data is updated yearly, averaging 0.020 Ratio from Dec 1990 (Median) to 2020, with 31 observations. The data reached an all-time high of 0.130 Ratio in 2020 and a record low of 0.010 Ratio in 2004. United Arab Emirates AE: Incidence of HIV: per 1,000 Uninfected Population data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s United Arab Emirates – Table AE.World Bank.WDI: Social: Health Statistics. Number of new HIV infections among uninfected populations expressed per 1,000 uninfected population in the year before the period.;UNAIDS estimates.;Weighted average;This is the Sustainable Development Goal indicator 3.3.1 [https://unstats.un.org/sdgs/metadata/].

  8. M

    Montenegro ME: Prevalence of HIV: Total: % of Population Aged 15-49

    • ceicdata.com
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    CEICdata.com, Montenegro ME: Prevalence of HIV: Total: % of Population Aged 15-49 [Dataset]. https://www.ceicdata.com/en/montenegro/health-statistics/me-prevalence-of-hiv-total--of-population-aged-1549
    Explore at:
    Dataset provided by
    CEICdata.com
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Dec 1, 2005 - Dec 1, 2016
    Area covered
    Montenegro
    Description

    Montenegro ME: Prevalence of HIV: Total: % of Population Aged 15-49 data was reported at 0.100 % in 2016. This stayed constant from the previous number of 0.100 % for 2015. Montenegro ME: Prevalence of HIV: Total: % of Population Aged 15-49 data is updated yearly, averaging 0.100 % from Dec 1990 (Median) to 2016, with 27 observations. The data reached an all-time high of 0.100 % in 2016 and a record low of 0.100 % in 2016. Montenegro ME: Prevalence of HIV: Total: % of Population Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Montenegro – Table ME.World Bank: Health Statistics. Prevalence of HIV refers to the percentage of people ages 15-49 who are infected with HIV.; ; UNAIDS estimates.; Weighted Average;

  9. T

    Finland - Prevalence Of HIV, Total (% Of Population Ages 15-49)

    • tradingeconomics.com
    csv, excel, json, xml
    Updated May 31, 2017
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2017). Finland - Prevalence Of HIV, Total (% Of Population Ages 15-49) [Dataset]. https://tradingeconomics.com/finland/prevalence-of-hiv-total-percent-of-population-ages-15-49-wb-data.html
    Explore at:
    csv, xml, json, excelAvailable download formats
    Dataset updated
    May 31, 2017
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 1976 - Dec 31, 2025
    Area covered
    Finland
    Description

    Prevalence of HIV, total (% of population ages 15-49) in Finland was reported at 0.1 % in 2018, according to the World Bank collection of development indicators, compiled from officially recognized sources. Finland - Prevalence of HIV, total (% of population ages 15-49) - actual values, historical data, forecasts and projections were sourced from the World Bank on June of 2025.

  10. T

    World - Children Orphaned By HIV/AIDS

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Jun 16, 2017
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2017). World - Children Orphaned By HIV/AIDS [Dataset]. https://tradingeconomics.com/world/children-orphaned-by-hiv-aids-wb-data.html
    Explore at:
    json, excel, csv, xmlAvailable download formats
    Dataset updated
    Jun 16, 2017
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 1976 - Dec 31, 2025
    Area covered
    World, World
    Description

    Children orphaned by HIV/AIDS in World was reported at 13900000 in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. World - Children orphaned by HIV/AIDS - actual values, historical data, forecasts and projections were sourced from the World Bank on June of 2025.

  11. Global HIV-AIDS Mortality by Country, 2023

    • reportlinker.com
    Updated Apr 9, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    ReportLinker (2024). Global HIV-AIDS Mortality by Country, 2023 [Dataset]. https://www.reportlinker.com/dataset/0cf1f8a42c6b4e0d23da62972aeb8841b7573084
    Explore at:
    Dataset updated
    Apr 9, 2024
    Dataset authored and provided by
    ReportLinker
    License

    Attribution-NonCommercial 4.0 (CC BY-NC 4.0)https://creativecommons.org/licenses/by-nc/4.0/
    License information was derived automatically

    Description

    Global HIV-AIDS Mortality by Country, 2023 Discover more data with ReportLinker!

  12. H

    Data from: Projecting the Future Budgetary Cost of AIDS Treatment in Poor...

    • dataverse.harvard.edu
    Updated Dec 12, 2014
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Owen McCarthy; Mead Over (2014). Projecting the Future Budgetary Cost of AIDS Treatment in Poor Countries: A Manual for the AIDSCost Computer Programs [Dataset]. http://doi.org/10.7910/DVN/28159
    Explore at:
    CroissantCroissant is a format for machine-learning datasets. Learn more about this at mlcommons.org/croissant.
    Dataset updated
    Dec 12, 2014
    Dataset provided by
    Harvard Dataverse
    Authors
    Owen McCarthy; Mead Over
    License

    CC0 1.0 Universal Public Domain Dedicationhttps://creativecommons.org/publicdomain/zero/1.0/
    License information was derived automatically

    Time period covered
    2006 - 2007
    Area covered
    World
    Description

    Every year, UNAIDS releases updated estimates of the number of people living with HIV and AIDS and the mortality impact of the epidemic, while WHO releases data on the number of people on treatment and the number needing treatment. This dataset, from CGD senior fellow Mead Over and Owen McCarthy, is a compilation of selected variables from these published sources as well as from the World Bank Development Indicators and the International Monetary Fund’s estimates of economic quantities such as Gross Domestic Product and central government health expenditures. The data are in the format developed by the Stata statistical software corporation and are intended for use with the AIDSCost package for the purpose of projecting the future budgetary cost of scaling up AIDS treatment. Instructions on how to download, access, and use the AIDSCost package are included in the users' manual. The authors encourage comments on their blog or as an e-mail to them, which will be considered for posting. (CGD’s HIV/AIDS Monitor Initiative provides access to data on past AIDS funding PEPFAR, the World Bank and the Global Fund.)

  13. c

    The global HIV drugs market size is USD 35425.2 million in 2024.

    • cognitivemarketresearch.com
    pdf,excel,csv,ppt
    Updated May 31, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Cognitive Market Research (2025). The global HIV drugs market size is USD 35425.2 million in 2024. [Dataset]. https://www.cognitivemarketresearch.com/hiv-drugs-market-report
    Explore at:
    pdf,excel,csv,pptAvailable download formats
    Dataset updated
    May 31, 2025
    Dataset authored and provided by
    Cognitive Market Research
    License

    https://www.cognitivemarketresearch.com/privacy-policyhttps://www.cognitivemarketresearch.com/privacy-policy

    Time period covered
    2021 - 2033
    Area covered
    Global
    Description

    According to Cognitive Market Research, the global HIV drugs market size will be USD 35425.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 6.80% from 2024 to 2031.

    North America held the major market share for more than 40% of the global revenue with a market size of USD 14170.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.0% from 2024 to 2031.
    Europe accounted for a market share of over 30% of the global revenue with a market size of USD 10627.56 million.
    Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 8147.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.8% from 2024 to 2031.
    Latin America had a market share of more than 5% of the global revenue with a market size of USD 1771.26 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.
    Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 708.50 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.
    The multi-class combination drugs held the highest HIV drugs market revenue share in 2024.
    

    Market Dynamics of HIV drugs Market

    Key Drivers for HIV drugs Market

    Rising number of HIV-positive individuals to Increase the Demand Globally

    The HIV drugs market has experienced growth due to rising number of HIV-positive individuals. As global HIV prevalence increases due to factors like higher transmission rates and improved diagnostic capabilities, demand for effective antiretroviral therapies (ART) surges. This growing patient base necessitates the continuous development and supply of innovative drugs to manage HIV effectively, reduce viral loads, and improve quality of life. Increased awareness and testing also contribute to higher diagnosed cases, further expanding the market for HIV treatments and driving pharmaceutical companies to invest in research and development.

    Innovations in HIV diagnostic tools to Propel Market Growth

    The HIV drugs market has witnessed steady growth, driven by innovations in HIV diagnostic tools. Advances include rapid, point-of-care tests that deliver results within minutes, improving patient access and reducing diagnostic delays. Integrated technologies, such as multiplex assays, detect multiple markers simultaneously, increasing diagnostic accuracy. Additionally, digital platforms for data management streamline monitoring and personalized treatment plans. These innovations not only improve patient outcomes but also stimulate demand for more effective HIV treatments and management solutions, fostering market growth.

    Restraint Factor for the HIV drugs Market

    High cost of HIV treatment to Limit the Sales

    The high costs of HIV medications constrain the growth of HIV drugs market. It involves expensive medications that can be unaffordable for many patients, especially in low-income regions. The costs are compounded by the need for lifelong treatment, regular monitoring, and potential side effects management, which further burdens healthcare systems and patients. This financial barrier limits access to effective treatment, leading to disparities in care and hindering efforts to control the HIV epidemic globally.

    Impact of Covid-19 on the HIV drugs Market

    The Covid-19 significantly impacted the market by disrupting supply chains, leading to delays in drug production and distribution, increasing lockdowns and restrictions. Additionally, the focus on COVID-19 diverted resources away from HIV programs, affecting drug availability and patient adherence. However, the pandemic also accelerated the adoption of telemedicine and digital health solutions, which helped maintain patient care continuity. Overall, the pandemic highlighted the need for resilient healthcare systems in managing chronic diseases. Introduction of the HIV drugs Market

    HIV drugs are medications used to treat Human Immunodeficiency Virus (HIV) infection. They work by suppressing the virus, preventing its replication, and protecting the immune system. These drugs are typically used in combination as antiretroviral therapy (ART) to reduce viral load, improve patient outcomes, and prevent the progression to AIDS. The rising number of HIV-positive individuals, advancemnets in drug development, increasing government initiatives and funding, increased aw...

  14. Global HIV AIDS Spending 2000 to 2015

    • johnsnowlabs.com
    csv
    Updated Jan 20, 2021
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    John Snow Labs (2021). Global HIV AIDS Spending 2000 to 2015 [Dataset]. https://www.johnsnowlabs.com/marketplace/global-hiv-aids-spending-2000-to-2015/
    Explore at:
    csvAvailable download formats
    Dataset updated
    Jan 20, 2021
    Dataset authored and provided by
    John Snow Labs
    Time period covered
    Jan 1, 2000 - Dec 31, 2015
    Area covered
    World
    Description

    This dataset provides estimates for Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) spending for 188 countries for 2000 to 2015. Data is taken from the Institute for Health Metrics and Evaluation (IHME) and the Global Health Data Exchange.

  15. H

    HIV and AIDS Clinical Trials Report

    • datainsightsmarket.com
    doc, pdf, ppt
    Updated Apr 27, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Data Insights Market (2025). HIV and AIDS Clinical Trials Report [Dataset]. https://www.datainsightsmarket.com/reports/hiv-and-aids-clinical-trials-591007
    Explore at:
    ppt, pdf, docAvailable download formats
    Dataset updated
    Apr 27, 2025
    Dataset authored and provided by
    Data Insights Market
    License

    https://www.datainsightsmarket.com/privacy-policyhttps://www.datainsightsmarket.com/privacy-policy

    Time period covered
    2025 - 2033
    Area covered
    Global
    Variables measured
    Market Size
    Description

    The global HIV and AIDS clinical trials market is experiencing robust growth, driven by the increasing prevalence of HIV/AIDS globally, coupled with ongoing efforts to develop more effective treatment regimens and preventative measures. The market's expansion is fueled by advancements in antiretroviral therapies (ARTs), a rise in research and development activities focusing on novel drug delivery systems, and a growing need for long-acting injectables to improve patient adherence. The pharmaceutical and biopharmaceutical sector is a major driver, investing heavily in clinical trials to bring innovative therapies to market, followed by significant contributions from non-profit organizations dedicated to HIV/AIDS research and patient support. While the market shows strong potential, challenges remain, such as the high cost associated with conducting clinical trials, particularly in resource-limited settings, and the complexity involved in conducting trials across diverse populations with varying disease presentations and access to healthcare. The segmentation by clinical trial phases (Phase I-IV) highlights the diverse stages of drug development and research contributing to the overall market. Geographical analysis reveals that North America and Europe currently hold significant market shares, though emerging economies in Asia-Pacific and Africa present substantial growth opportunities due to increasing prevalence rates and rising government initiatives focused on HIV/AIDS control. Further analysis suggests a promising outlook for the market, with continued growth projected throughout the forecast period (2025-2033). The development of new combination therapies, personalized medicine approaches, and strategies targeting viral reservoirs are expected to further fuel market expansion. The success of these efforts hinges on collaborative partnerships between pharmaceutical companies, research institutions, and governmental bodies to overcome logistical hurdles, ensuring equitable access to cutting-edge treatments and diagnostics across different regions of the world. Effective strategies targeting underserved populations and addressing socio-economic barriers to access will be crucial in maximizing the impact of clinical trials and improving global HIV/AIDS outcomes. The focus on long-acting medications and new approaches like gene therapy are poised to reshape the landscape of HIV/AIDS clinical trials in the coming years.

  16. Belgium HIV prevalence among population aged 15-49

    • knoema.com
    csv, json, sdmx, xls
    Updated Apr 30, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Knoema (2025). Belgium HIV prevalence among population aged 15-49 [Dataset]. https://knoema.com/atlas/Belgium/topics/Health/Risk-factors/HIV-prevalence-among-population-aged-15-49
    Explore at:
    sdmx, csv, json, xlsAvailable download formats
    Dataset updated
    Apr 30, 2025
    Dataset authored and provided by
    Knoemahttp://knoema.com/
    Time period covered
    2011 - 2022
    Area covered
    Belgium
    Variables measured
    HIV prevalence among population aged 15-49
    Description

    HIV prevalence among population aged 15-49 of Belgium remained constant at 0.2 % over the last 10 years. Prevalence of HIV refers to the percentage of people ages 15-49 who are infected with HIV.

  17. M

    Mexico MX: Prevalence of HIV: Male: % Aged 15-24

    • ceicdata.com
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    CEICdata.com, Mexico MX: Prevalence of HIV: Male: % Aged 15-24 [Dataset]. https://www.ceicdata.com/en/mexico/health-statistics/mx-prevalence-of-hiv-male--aged-1524
    Explore at:
    Dataset provided by
    CEICdata.com
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Dec 1, 2006 - Dec 1, 2017
    Area covered
    Mexico
    Description

    Mexico MX: Prevalence of HIV: Male: % Aged 15-24 data was reported at 0.200 % in 2017. This stayed constant from the previous number of 0.200 % for 2016. Mexico MX: Prevalence of HIV: Male: % Aged 15-24 data is updated yearly, averaging 0.200 % from Dec 1990 (Median) to 2017, with 28 observations. The data reached an all-time high of 0.200 % in 2017 and a record low of 0.100 % in 2009. Mexico MX: Prevalence of HIV: Male: % Aged 15-24 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Mexico – Table MX.World Bank.WDI: Health Statistics. Prevalence of HIV, male is the percentage of males who are infected with HIV. Youth rates are as a percentage of the relevant age group.; ; UNAIDS estimates.; Weighted average; In many developing countries most new infections occur in young adults, with young women being especially vulnerable.

  18. Italy IT: Incidence of HIV: % of Uninfected Population Aged 15-49

    • ceicdata.com
    Updated May 8, 2018
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    CEICdata.com (2018). Italy IT: Incidence of HIV: % of Uninfected Population Aged 15-49 [Dataset]. https://www.ceicdata.com/en/italy/health-statistics
    Explore at:
    Dataset updated
    May 8, 2018
    Dataset provided by
    CEIC Data
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Dec 1, 2005 - Dec 1, 2016
    Area covered
    Italy
    Description

    IT: Incidence of HIV: % of Uninfected Population Aged 15-49 data was reported at 0.010 % in 2016. This stayed constant from the previous number of 0.010 % for 2015. IT: Incidence of HIV: % of Uninfected Population Aged 15-49 data is updated yearly, averaging 0.020 % from Dec 1990 (Median) to 2016, with 27 observations. The data reached an all-time high of 0.040 % in 1995 and a record low of 0.010 % in 2016. IT: Incidence of HIV: % of Uninfected Population Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Italy – Table IT.World Bank: Health Statistics. Number of new HIV infections among uninfected populations ages 15-49 expressed per 100 uninfected population in the year before the period.; ; UNAIDS estimates.; Weighted Average;

  19. I

    Iraq Prevalence of HIV: Total: % of Population Aged 15-49

    • ceicdata.com
    Updated Jun 8, 2024
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    CEICdata.com (2024). Iraq Prevalence of HIV: Total: % of Population Aged 15-49 [Dataset]. https://www.ceicdata.com/en/iraq/social-health-statistics/prevalence-of-hiv-total--of-population-aged-1549
    Explore at:
    Dataset updated
    Jun 8, 2024
    Dataset provided by
    CEICdata.com
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Dec 1, 2011 - Dec 1, 2022
    Area covered
    Iraq
    Description

    Iraq Prevalence of HIV: Total: % of Population Aged 15-49 data was reported at 0.100 % in 2022. This stayed constant from the previous number of 0.100 % for 2021. Iraq Prevalence of HIV: Total: % of Population Aged 15-49 data is updated yearly, averaging 0.100 % from Dec 1990 (Median) to 2022, with 33 observations. The data reached an all-time high of 0.100 % in 2022 and a record low of 0.100 % in 2022. Iraq Prevalence of HIV: Total: % of Population Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Iraq – Table IQ.World Bank.WDI: Social: Health Statistics. Prevalence of HIV refers to the percentage of people ages 15-49 who are infected with HIV.;UNAIDS estimates.;Weighted average;

  20. T

    United States - Prevalence Of HIV, Total (% Of Population Ages 15-49)

    • tradingeconomics.com
    csv, excel, json, xml
    Updated May 29, 2017
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2017). United States - Prevalence Of HIV, Total (% Of Population Ages 15-49) [Dataset]. https://tradingeconomics.com/united-states/prevalence-of-hiv-total-percent-of-population-ages-15-49-wb-data.html
    Explore at:
    xml, csv, excel, jsonAvailable download formats
    Dataset updated
    May 29, 2017
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 1976 - Dec 31, 2025
    Area covered
    United States
    Description

    Prevalence of HIV, total (% of population ages 15-49) in United States was reported at 0.4 % in 2021, according to the World Bank collection of development indicators, compiled from officially recognized sources. United States - Prevalence of HIV, total (% of population ages 15-49) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

Share
FacebookFacebook
TwitterTwitter
Email
Click to copy link
Link copied
Close
Cite
Globalen LLC (2015). HIV infections by country, around the world | TheGlobalEconomy.com [Dataset]. www.theglobaleconomy.com/rankings/HIV_infections/

HIV infections by country, around the world | TheGlobalEconomy.com

Explore at:
xml, excel, csvAvailable download formats
Dataset updated
Apr 24, 2015
Dataset authored and provided by
Globalen LLC
License

Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically

Time period covered
Dec 31, 1990 - Dec 31, 2022
Area covered
World, World
Description

The average for 2022 based on 135 countries was 1.66 percent. The highest value was in Swaziland: 25.9 percent and the lowest value was in Afghanistan: 0.1 percent. The indicator is available from 1990 to 2022. Below is a chart for all countries where data are available.

Search
Clear search
Close search
Google apps
Main menu